Most compounding pharmacies and 503B facilities are being incorrectly treated as “high risk” by processors that do not understand the space.
Dont significant interchange savings on commercial card transactions.
https://t.co/edYi468OBY
#503B#CompoundingPharmacy
If you’re offering B2B payment terms Net 30, Net 60, or anything in between there’s a cost sitting in your receivables right now that doesn’t show up on any invoice and almost nobody in B2B ever talks about. https://t.co/UNITJFPy04
#B2Bpayments#DSO#Workingcapital#cashflow